TRAVERSA SERGIO (CIK 1565832) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-16). Recent activity: Buy RLMD (27,500 shares), Buy RLMD (272,500 shares), Buy RLMD (80,545 shares), Buy RLMD (129,455 shares), Buy RLMD (55,976 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 27,500 | $113,300 |
| 2025-11-06 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 272,500 | $599,500 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 80,545 | $49,938 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 129,455 | $86,735 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 55,976 | $41,422 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 172,314 | $77,541 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 30,000 | $15,000 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | Buy | 147,686 | $82,704 |
Source: SEC Form 4 filings · as of 2025-12-16